Clinical Trials Directory

Trials / Completed

CompletedNCT05347667

Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on Muscle Protein Synthesis

Influence of Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on the Muscle Protein Synthetic Response to Exercise in Young, Healthy Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
McMaster University · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Skeletal muscle size and function is regulated by various factors, including hormones. While we understand the role of male sex hormones (testosterone), we aren't sure how female sex hormones (estrogen and progesterone) influence muscle mass and strength. Female physiology is unique in that hormones fluctuate throughout the menstrual cycle. In the first phase (follicular phase) following menstruation, estrogen levels are high while progesterone levels are low. In the second phase (luteal phase), progesterone levels are high. Females are often excluded from studies because researchers are concerned that the menstrual cycle might affect the results. The purpose of this study is to investigate the response to resistance exercise in each phase of the menstrual cycle.

Conditions

Interventions

TypeNameDescription
OTHERUnilateral Resistance Exercise LegOne leg will perform unilateral resistance exercise
OTHERControl LegOne leg will serve as a non-exercise control

Timeline

Start date
2022-05-01
Primary completion
2023-03-01
Completion
2024-04-30
First posted
2022-04-26
Last updated
2025-01-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05347667. Inclusion in this directory is not an endorsement.